Latest ADAR1 Capital Management, LLC Stock Portfolio
ADAR1 Capital Management, LLC Performance:
2024 Q4: -2.91%YTD: 5.39%
Performance for 2024 Q4 is -2.91%, and YTD is 5.39%.
About ADAR1 Capital Management, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, ADAR1 Capital Management, LLC reported an equity portfolio of $500.4 Millions as of 31 Dec, 2024.
The top stock holdings of ADAR1 Capital Management, LLC are ROIV, PTGX, BOB. The fund has invested 8.3% of it's portfolio in ROIVANT SCIENCES LTD and 7.9% of portfolio in PROTAGONIST THERAPEUTICS INC.
The fund managers got completely rid off Q32 BIO INC, PIERIS PHARMACEUTICALS INC (PIRS) and ENVVENO MEDICAL CORPORATION (NVNO) stocks. They significantly reduced their stock positions in ROYALTY PHARMA PLC (RPRX), KEROS THERAPEUTICS INC (KROS) and BIOGEN INC (BIIB). ADAR1 Capital Management, LLC opened new stock positions in INHIBIKASE THERAPEUTICS INC (IKT), ANTERIS TECHNOLOGIES GLOBAL and MONOPAR THERAPEUTICS INC (MNPR). The fund showed a lot of confidence in some stocks as they added substantially to PHATHOM PHARMACEUTICALS INC (PHAT), RAPT THERAPEUTICS INC (RAPT) and ACHIEVE LIFE SCIENCES INC (ACHV).
The top stock holdings of ADAR1 Capital Management, LLC are ROIV, PTGX, BOB. The fund has invested 8.3% of it's portfolio in ROIVANT SCIENCES LTD and 7.9% of portfolio in PROTAGONIST THERAPEUTICS INC.
The fund managers got completely rid off Q32 BIO INC, PIERIS PHARMACEUTICALS INC (PIRS) and ENVVENO MEDICAL CORPORATION (NVNO) stocks. They significantly reduced their stock positions in ROYALTY PHARMA PLC (RPRX), KEROS THERAPEUTICS INC (KROS) and BIOGEN INC (BIIB). ADAR1 Capital Management, LLC opened new stock positions in INHIBIKASE THERAPEUTICS INC (IKT), ANTERIS TECHNOLOGIES GLOBAL and MONOPAR THERAPEUTICS INC (MNPR). The fund showed a lot of confidence in some stocks as they added substantially to PHATHOM PHARMACEUTICALS INC (PHAT), RAPT THERAPEUTICS INC (RAPT) and ACHIEVE LIFE SCIENCES INC (ACHV).
ADAR1 Capital Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that ADAR1 Capital Management, LLC made a return of -2.91% in the last quarter. In trailing 12 months, it's portfolio return was 5.39%.
New Buys
| Ticker | $ Bought |
|---|---|
| inhibikase therapeutics inc | 16,584,800 |
| anteris technologies global | 5,875,560 |
| coherus biosciences inc | 5,477,620 |
| oaktree acquisition corp iii | 5,065,000 |
| sanofi | 4,803,710 |
| gossamer bio inc | 4,355,210 |
| bridgebio pharma inc | 3,861,000 |
| monopar therapeutics inc | 2,860,810 |
New stocks bought by ADAR1 Capital Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| phathom pharmaceuticals inc | 27,600 |
| rapt therapeutics inc | 15,557 |
| achieve life sciences inc | 14,375 |
| 89bio inc | 7,752 |
| rocket pharmaceuticals inc | 4,816 |
| axsome therapeutics inc | 3,176 |
| organon & co | 1,196 |
| contineum therapeutics inc | 817 |
Additions to existing portfolio by ADAR1 Capital Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| royalty pharma plc | -95.44 |
| keros therapeutics inc | -94.78 |
| biogen inc | -89.72 |
| solid biosciences inc | -87.00 |
| abcellera biologics inc | -86.97 |
| alkermes plc | -86.31 |
| anaptysbio inc | -85.83 |
| dianthus therapeutics inc | -85.11 |
ADAR1 Capital Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| biomx inc | -441,354 |
| envveno medical corporation | -1,170,160 |
| beyond air inc | -109,467 |
| revance therapeutics inc | -945,442 |
| vyne therapeutics inc | -287,386 |
| pieris pharmaceuticals inc | -2,398,150 |
| fibrogen inc | -48,193 |
| aclaris therapeutics inc | -103,500 |
ADAR1 Capital Management, LLC got rid off the above stocks
Sector Distribution
ADAR1 Capital Management, LLC has about 65.2% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 65.2 |
| Others | 33.4 |
| Communication Services | 1.4 |
Market Cap. Distribution
ADAR1 Capital Management, LLC has about 9.1% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 37.6 |
| UNALLOCATED | 33.4 |
| LARGE-CAP | 9.1 |
| SMALL-CAP | 9.1 |
| NANO-CAP | 6.1 |
| MICRO-CAP | 4.3 |
Stocks belong to which Index?
About 36.6% of the stocks held by ADAR1 Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 63.5 |
| RUSSELL 2000 | 35.5 |
| S&P 500 | 1.1 |
ADAR1 Capital Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of ADAR1 Capital Management, LLC
ADAR1 Capital Management, LLC has 195 stocks in it's portfolio. About 48.3% of the portfolio is in top 10 stocks. PTGX proved to be the most loss making stock for the portfolio. IKT was the most profitable stock for ADAR1 Capital Management, LLC last quarter.
Last Reported on: 13 Feb, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABCL | abcellera biologics inc | 0.01 | 14,981 | 43,894 | reduced | -86.97 | ||
| ABEO | abeona therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ABOS | acumen pharmaceuticals inc | 0.03 | 94,294 | 162,186 | new | |||
| ABSI | absci corporation | 0.08 | 157,665 | 413,082 | reduced | -84.32 | ||
| ABUS | arbutus biopharma corp | 1.02 | 1,554,800 | 5,084,200 | reduced | -25.58 | ||
| ACAD | acadia pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ACHV | achieve life sciences inc | 0.01 | 13,173 | 46,369 | added | 14,375 | ||
| ACLX | arcellx inc | 0.06 | 3,962 | 303,846 | unchanged | 0.00 | ||
| ACRS | aclaris therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ADXN | addex therapeutics ltd | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AGIO | agios pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AGLE | spyre therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AGR | avangrid inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AIMAU | aimfinity investment corp i | 0.00 | 18,000 | 126 | unchanged | 0.00 | ||
| AKRO | akero therapeutics inc | 0.09 | 15,307 | 425,841 | reduced | -33.47 | ||
| ALCC | oklo inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALDX | aldeyra therapeutics inc | 0.65 | 647,960 | 3,233,320 | added | 114 | ||
| ALEC | alector inc | 0.14 | 368,330 | 696,144 | reduced | -14.1 | ||
| ALKS | alkermes plc | 0.06 | 10,188 | 293,007 | reduced | -86.31 | ||
| ALLK | allakos inc | 0.01 | 62,264 | 75,339 | new | |||